- Home
- VERO vs AZTR Comparison
VERO vs AZTR Comparison
Compare VERO & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- AZTR
- Stock Information
- Founded
- VERO N/A
- AZTR 2014
- Country
- VERO Canada
- AZTR United States
- Employees
- VERO N/A
- AZTR N/A
- Industry
- VERO Medical/Dental Instruments
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- AZTR Health Care
- Exchange
- VERO Nasdaq
- AZTR Nasdaq
- Market Cap
- VERO 4.9M
- AZTR 4.0M
- IPO Year
- VERO N/A
- AZTR 2023
- Fundamental
- Price
- VERO $2.58
- AZTR $0.22
- Analyst Decision
- VERO
- AZTR
- Analyst Count
- VERO 0
- AZTR 0
- Target Price
- VERO N/A
- AZTR N/A
- AVG Volume (30 Days)
- VERO 1.1M
- AZTR 798.9K
- Earning Date
- VERO 08-14-2025
- AZTR 08-11-2025
- Dividend Yield
- VERO N/A
- AZTR N/A
- EPS Growth
- VERO N/A
- AZTR N/A
- EPS
- VERO N/A
- AZTR N/A
- Revenue
- VERO $60,997,000.00
- AZTR $7,500.00
- Revenue This Year
- VERO N/A
- AZTR N/A
- Revenue Next Year
- VERO $7.47
- AZTR N/A
- P/E Ratio
- VERO N/A
- AZTR N/A
- Revenue Growth
- VERO N/A
- AZTR N/A
- 52 Week Low
- VERO $2.10
- AZTR $0.21
- 52 Week High
- VERO $14.50
- AZTR $1.25
- Technical
- Relative Strength Index (RSI)
- VERO 51.60
- AZTR 37.04
- Support Level
- VERO $2.42
- AZTR $0.22
- Resistance Level
- VERO $2.71
- AZTR $0.24
- Average True Range (ATR)
- VERO 0.17
- AZTR 0.01
- MACD
- VERO -0.00
- AZTR -0.00
- Stochastic Oscillator
- VERO 26.09
- AZTR 7.97
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.